chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bad headache    Throwing up Severe chills      Could barley walk and move Severe body aches    Skin hurts so bad-wanted to rip it off Severe stomach pain   Very sensitive to sound, lights and smells Vision blurry Fever
Information has been received from a grandmother who reported that there was "too much evidence that side effects did occur with" MMR II. The reporter stated the vaccine had the side effects that she believed to be attached to autism. The reporter spoke with different parents that after the vaccination of MMR II the child was different "in a bad way". The reporter stated the children were different in the speech, no emotion, difficult behavior, abdominal problems. The outcome of the patients was not reported. Upon internal overview, autism was determined to be an other important medical event. Additional information has been requested.
Member was given tetanus vaccine instead of typhoid on 30 jan 23 then given was given thphoid on 31 jan 23. woke up with swelling face on 1 Feb. and again on 2 Feb. member refused treatment. swelling dissipated on its own within 1-2hrs.
On 7/2 I woke up with numbness in left arm and hand. On 7/2/2022 I was diagnosed with having a Transient Ischemic Attack (TIA Stroke) to the left side.
Malaise; Febrile; Night sweat; Sore arm; This is a spontaneous report from a contactable consumer. A 60-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 13Jan2021 at a single dose in the right arm for Covid-19 immunization. The patient's medical history was not reported. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included varicella zoster vaccine rge (cho) (SHINGRIX, booster) on 08Jan2021 (within 4 weeks) in the left arm, ibuprofen, acetaminophen and thyroid medicine (unspecified). The vaccination was administered in the hospital. On 14Jan2021 08:00 AM, patient experienced malaise, febrile, night sweat, and sore arm. No treatments were received in response to the events. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). The events malaise, febrile, night sweat, and sore arm were recovering at the time of the report.   Information on the lot/batch number has been requested.
Soreness to arm and when I move it in certain ways feels like someone is stabbing me with ice pick. Has progressed to the point the cannot lift arm over shoulder height.
Developed blister link rash over both thighs and had fever. This all happened approximately equal to 24 hours after receiving 6 shots.
Beginning around midnight, started with abdominal pain, nausea, aches. Continued all the next day, and included fever, chills, fatigue . Next day (today) 3/31/21, developed intestinal issues, continuing fatigue but diminishing in severity. Treated with ibuprofen and acetaminophen.
is experiencing joint swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 06Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer covid-19 vaccine (DOSE 1, SINGLE), administration date: 13Feb2021, for Covid 19 immunization. The following information was reported: JOINT SWELLING (non-serious) with onset 2021, outcome "unknown", described as "is experiencing joint swelling".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Had high fever , chills , then began coughing bronchitis like lung pain short of breath
Information has been received from a registered nurse (R.N.) concerning a patient who on 03-APR-2001, 4 day early prior to the patient's first year birthday, was vaccinated with a dose of VARIVAX (Merck) (lot number, injection site and route not reported) and MMR II. No AE was reported. No product quality complain was involved. Follow-up information was received from the R.N. on 15-JUL-2008. She reported that there was "no adverse reaction". The patient simply got shingles after having had the vaccine. He recovered without incident. Additional information is not expected.
Heart attack symptoms resulting from cardiac event, leading to hospitalization for 4 days. Diagnosed with Myocarditis.
Arm heaviness shortly after vaccine was administered. Swelling and soreness at injection site 7 hours after vaccine was administered.    Body aches 13 hours after vaccine was administered Brain fog, fever, and chills 21 hours after vaccine was administered. Symptoms lasted 48 hours.
A report was received from a healthcare professional in the US on 11/1/05, concerning a 6 year old female vaccinee. No details were provided regarding the vaccinee's concomitant medications. The vaccinee was already hospitalized for other reasons that were not reported. On 10/28/05, the vaccinee received Fluvirin (batch 61122), IM. On 10/30/05, the vaccinee began to experience 6 movement disorder. She was evaluated by a neurologist and the symptoms were not classified as tics but as polymyoclonia. Follow up information will be sought. (OMIC)
Rash on same arm of injection; Arm swollen; Arm tight, arm hard; Covid arm; Arm red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Arm red), VACCINATION SITE RASH (Rash on same arm of injection), VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE DISCOMFORT (Arm tight, arm hard) and COVID-19 (Covid arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, GLIPIZIDE, CETIRIZINE, LATANOPROST, FLUTICASONE, DILTIAZEM, LEVOTHYROXINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm red), VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE DISCOMFORT (Arm tight, arm hard) and COVID-19 (Covid arm). On 06-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash on same arm of injection). At the time of the report, VACCINATION SITE ERYTHEMA (Arm red), VACCINATION SITE RASH (Rash on same arm of injection), VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE DISCOMFORT (Arm tight, arm hard) and COVID-19 (Covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On 27-NOV-2018, the patient was vaccinated with an improperly stored dose of VAQTA lot # R013859, expiration date on 14-JUN-2019, for prophylaxis (strength, dose, route of administration and anatomical location were not reported). The vaccine was improperly stored at a temperature between 32°F to 35°F during a time frame of 30 minutes and between 47°F to 77°F for 30 minutes. No previous temperature excursions neither adverse effects were reported. The call was because of a data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1811USA012115: US-009507513-1811USA012111.
Information has been received from a pharmacist referring to a 67 year old female patient. Medical history or concurrent condition was not reported. In approximately 2013 reported as "around 2 years ago", the patient was vaccinated with ZOSTAVAX (dosage, strength, route and lot # were not reported). Concomitant medication was reported. In approximately April 2015 (reported as "around 6 months ago"), the patient developed shingles on an unspecified date. The patient sought unspecified medical attention. The reporter stated that the patient had experienced a rash that "wrapped around her abdomen and back" which her unspecified physician told her was shingles. The pharmacist stated that the patient might have been prescribed an unspecified dose of acyclovir at the time to treat the rash by healthcare provider. On an unspecified date in 2015, the patient experienced post-herpetic nerve pain and the pharmacist reported that the patient continued to experience post-herpetic nerve pain. Outcome of the adverse events was not recovered. Additional information has been requested.
Shortly after receiving the vaccine, she felt hot, nauseous and legs felt "like jello."
Narrative: 11/02 COVID vaccine dose#1 11/03 seen in ED with c/o facial hives; no information provided regarding treatment, not admitted 11/12 seen by PCP, symptoms not mentioned, likely resolved
Massive headache on left side of head; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 03Apr2021 at 13:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included depression from an unknown date. The patient was not allergic to any medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 16:00 the patient experienced a massive headache on the left side of the head. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event massive headache on the left side of the head was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
it seems a little red; swelled; booster; got a little sore; hurting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient received bnt162b2 (Pfizer COVID 19 Vaccine- Solution for injection), administered in arm right, administration date 22Dec2021 (Lot number: 33025BD) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, LOT# of first shot: EW0158), administration date: 02Apr2021, when the patient was 53 years old, for COVID-19 Immunization; Bnt162b2 (2nd dose, LOT# of second shot: EW0164), administration date: 03May2021, when the patient was 53 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 22Dec2021, outcome "unknown", described as "booster"; VACCINATION SITE PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "got a little sore"; PAIN (non-serious) with onset 22Dec2021, outcome "not recovered", described as "hurting"; INJECTION SITE ERYTHEMA (non-serious) with onset 23Dec2021, outcome "not recovered", described as "it seems a little red"; SWELLING (non-serious) with onset 23Dec2021, outcome "not recovered", described as "swelled". Therapeutic measures were not taken as a result of vaccination site pain, pain, injection site erythema, swelling.  Additional information: she got a little sore (Further clarification unknown hence event captured as per verbatim) after came back to apartment and it was been hurting and today (date not specified) it seems a little red and it was swelled and that was still hurting." No follow-up attempts are possible. Information about batch number cannot be obtained.Vaccination facility: Consumer stated, "The first two was done at the withheld. Done by Regulatory authority." Prior to the vaccination, the patient was not diagnosed with COVID-19.
Big redness, soreness and swelling. Patient contacted MD and was given KEFLEX - antibiotic.
sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. Most recently, the patient had a shot of Shingles and got the side effects which led to sickness. Batch number and expiration date was not reported.
Pt recvd 2nd dose of Engerix-B & @ 730PM 114MAR91 pt became flushed, weakness, profuse sweating, devel welt under eye;
Patient is 16 years old and was administered Moderna.  Parent received EUA and completed consent.  No adverse reaction after vaccination.
Don't remember the whole next day with the exception of a minute in the morning when my husband was stepping on my left arm and I was on the floor beside the bed, telling me to get up and take care of him ( he has dementia) and then in the late afternoon and I'm on the floor in the living room and  my husband is stepping on my left hand and is telling me to get up and take care of him.   I remember nothing until the next morning when I got up and was normal.  Took my blood pressure and it was 97/50. I have high blood pressure.   I have no idea of how I functioned.
woke up in the middle of the night with fever; nausea; foot started to hurt, bottom of it and pain in the top back of left thigh; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (foot started to hurt, bottom of it and pain in the top back of left thigh) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced PAIN IN EXTREMITY (foot started to hurt, bottom of it and pain in the top back of left thigh) (seriousness criterion medically significant). On 18-May-2021, the patient experienced PYREXIA (woke up in the middle of the night with fever) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (foot started to hurt, bottom of it and pain in the top back of left thigh), PYREXIA (woke up in the middle of the night with fever) and NAUSEA (nausea) outcome was unknown.            Concomitant medication included birth control pills, not otherwise specified. Treatment included ibuprofen.  Company comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: could not eat the day after vaccine-Medium, Additional Details: Pt stated the day after vaccine (1/12/23) she felt sick all day and could not eat. Arm became painful, red, swollen, and warm beginning Friday 1/13/23. Pt is trying to schedule an appt at an urgent care. Recommended follow up with PCP as well to determine whether 2nd dose should be taken.
Aching both arms radiating down back and feet, SOB, freezing cold, T 102.8, and nonproductive cough.
59 year old male who developed severe back pain, leg weakness and numbness in hands and feet 3 weeks after H1N1 vaccination. Thorough initial EMG was unremarkable, f/u EMG 4 weeks after onset shows acquired demyelination - GBS
Pain radiating from left shoulder to chest, upper back and neck. Lightheadedness, weakness and chills x 3 weeks.
very late getting second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (very late getting second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (very late getting second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (very late getting second shot) had resolved.            No Concomitant drugs were reported.  No Treatment information  were reported.   This case was linked to MOD-2021-295739 (Patient Link).
The menstrual period started with an abnormally high flow for 3 -4 months and then skipped a month. 10 days of progesterone were prescribed and waiting for the next period to see if it is now regular.
(2) 30 sec blue/limp spells p/crying from hitting tender leg;
Patient can't raise the arm that he received a Prevnar 13 vaccine in; she believes it is the patient's left arm that is affected; This is a spontaneous report from a contactable Other HCP via Pfizer Sales Representative. This Other HCP reported for a 70-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on left arm on 15Jul2020 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient can't raise the arm that he received the Prevnar 13 vaccine in. The reporter stated that it has been two weeks since the patient received the Prevnar 13 vaccine and the patient still can't raise his arm that received the Prevnar 13 vaccine. The patient was having difficulty getting dressed and working in the yard and gardening. The Pfizer sales representative stated the patient had no other vaccines administered along with the Prevnar 13 vaccine. The reporter clarified she believed it was the patient's left arm that was affected. She stated she knew the patient received the same Prevnar 13 dose that a pediatric patient would get, but was unable to confirm what the exact Prevnar 13 dose was. The outcome of the event was not recovered.  No follow-up attempts are possible, information about batch number cannot be obtained.
Patient states that her arm (Left) hurt bad a few hours after receiving the flu shot. She also states that she had tingling and numbness in the left arm.
he lost feelings in legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "he lost feelings in legs".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain, hardness, tender to touch  in left arm a few inches below site of shot in deltoid 1 day after. 3 days after patient experienced shift of redness, pain, area of tenderness to inside of bicep.
Patient states he experienced severe headache, body aches, and dizziness/vertigo for days after receiving vaccination.
Rash 3 weeks after vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (Rash 3 weeks after vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash 3 weeks after vaccine). At the time of the report, RASH (Rash 3 weeks after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.